Birchview Capital »

Kayne Anderson BDC shares owned by Birchview Capital

Quarter-by-quarter ownership of Kayne Anderson BDC (KBDC) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Kayne Anderson BDC

Tip: Access up to 7 years of quarterly data

All positions including Kayne Anderson BDC held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kayne Anderson BDC by Birchview Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $286k 20k 14.32

More positions owned by Birchview Capital

Kla Corporation Com New (KLAC)
Bristol Myers Squibb (BMY)
Compass Therapeutics (CMPX)
Stoke Therapeutics (STOK)
Lam Research Corporation Com New (LRCX)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Spons Adr (GPCR)
Protagonist Therapeutics (PTGX)
ACADIA Pharmaceuticals (ACAD)
Encana Corporation (OVV)
Prothena Corp SHS (PRTA)
Solid Biosciences Com New (SLDB)
Neurocrine Biosciences (NBIX)
Amicus Therapeutics (FOLD)
Bicycle Therapeutics Sponsored Ads (BCYC)

View all positions for Birchview Capital

Top funds holding Kayne Anderson BDC

Koch
State Treasurer State Of Michigan
Pathstone Holdings
Van Eck Associates Corp.
Sage Mountain Advisors
Requisite Capital Management
Franklin Resources
UBS Group
BlackRock
CI Private Wealth
Callodine Capital Management
Rivernorth Capital Management
Squarepoint Ops
HB Wealth Management
Activest Wealth Management

View all funds holding Kayne Anderson BDC